10.85 -0.04 (-0.37%)
VASC
| Trade VASC now with |
|
Stock Details
Last Trade:10.85 Change:-0.04 (-0.37%) Prev Close:10.89 Open: 10.90 Days Range:10.73 – 10.97 52 Week Range: 9.90 - 13.75 Volume:99753 P/E: 19.04EPS:0.57
View AllRecent Alerts 02/09/12
Recent Alert on 02/02/12 at 9:33am
Canaccord Genuity Maintains a 'Buy' on Vascular Solutions (VASC); Q4 Mixed; 2012 Looks Like Transition Year
Canaccord Genuity Maintains a 'Buy' on Vascular Solutions (VASC); Q4 Mixed; 2012 Looks Like Transition Year
Canaccord Genuity maintains a 'Buy' on Vascular Solutions (NASDAQ: VASC) price target cut to $14.00. Analyst, Jason R. Mills, said, "Q4 sales were slightly lower than expected, as the launch of Pronto V4 was delayed again. VASC expects its new... Read More
Recent Alert on 02/01/12 at 4:20pm
Vascular Solutions, Inc. (VASC) Reports In-Line Q4 EPS of $0.13, Offers FY12 Guidance
Vascular Solutions, Inc. (VASC) Reports In-Line Q4 EPS of $0.13, Offers FY12 Guidance
Recent Alert on 02/01/12 at 4:20pm
Vascular Solutions, Inc. (VASC) Reports In-Line Q4 EPS of $0.13, Offers FY12 Guidance
Vascular Solutions, Inc. (VASC) Reports In-Line Q4 EPS of $0.13, Offers FY12 Guidance
Recent Alert on 01/31/12 at 5:47pm
Trading Radar for 02/01: Las Vegas Sands (LVS), Whirlpool (WHR), Shutterfly (SFLY), Northrop Grumman (NOC), Marathon Oil (MRO) Report
Trading Radar for 02/01: Las Vegas Sands (LVS), Whirlpool (WHR), Shutterfly (SFLY), Northrop Grumman (NOC), Marathon Oil (MRO) Report
Recent Alert on 12/07/11 at 11:06am
Highlights From Canaccord Genuity Cardiovascular, Aesthetics & Metabolic Disorders Conference Part III
Highlights From Canaccord Genuity Cardiovascular, Aesthetics & Metabolic Disorders Conference Part III
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
SEC Filing on 02/08/12 at 10:51am
Form 4 VASCULAR SOLUTIONS INC For: Feb 07 Filed by: CHRISTIAN SUSAN
Form 4 VASCULAR SOLUTIONS INC For: Feb 07 Filed by: CHRISTIAN SUSAN
View AllRecent Blog Posts
Blog Posts on 11/22/11 at 4:16am
3 Attractive, Low P/E Ratio Stocks And More With Safe Credit Scores
3 Attractive, Low P/E Ratio Stocks And More With Safe Credit Scores
Blog Posts on 11/15/11 at 7:34am
Despite Weak Q3 Results Vascular Solutions Continues To Look Like A Good Long-Term Buy
Despite Weak Q3 Results Vascular Solutions Continues To Look Like A Good Long-Term Buy
Blog Posts on 08/30/10 at 3:20am
Vascular Solutions Is One of the Industry's Attractive Takeover Targets
Vascular Solutions Is One of the Industry's Attractive Takeover Targets